FDA approves drug to prevent breast cancer
A new drug called raloxifene has been approved by the FDA. It helps older women be less likely to get breast cancer. It also helps women whose bones are thinning with age (osteoporosis).
The brand name of the drug is Evista. Many women in the United States already take it for their bones. The one problem is the side effects: the drug can cause blood clots in the legs, stroke, hot flashes, leg cramps, swelling in legs and feet, flu-like symptoms, joint pain and sweating.
Doctors are saying that for many women, the benefit of taking raloxifene is stronger than the risks. But only time will tell if women will choose to take it.
According to doctors, if enough women take raloxifene, there may be less overall cases of breast cancer in the world.
September 15, 2007 By Meghan Connelly, SEE Newscaster
************************************************************************
*DISCUSSION QUESTIONS
Do you think that all older women should take this drug?
Do you feel like the benefits outweigh the risks of this drug?
************************************************************************
FKRL 6.7
